Colorectal cancer (CRC) is still a leading cause of cancer death worldwide. Less than half of
cases are diagnosed when the cancer is locally advanced. CRC is a heterogenous disease …

Background Colorectal cancer (CRC) is the second leading cause of cancer deaths in Hong
Kong. We tested the hypothesis that circulating tumor cell (CTC) analysis by ARB101 …

The study is aimed to evaluate the diagnostic and prognostic role of the
immunohistochemical expression of the Caudal-type homeobox transcription factor 2 …

Immunotherapy development against colorectal cancer (CRC) is hindered by the lack of cell
surface target highly expressed in cancer cells but with restricted presence in normal tissues …

Abstract Cadherin-17 (CDH17) is a membranous cell adhesion protein predominantly
expressed in intestinal epithelial cells. CDH17 is therefore considered a possible diagnostic …

Colorectal cancer (CRC) remains one of the most common malignancies worldwide, and
liver metastasis represents a considerable challenge during CRC treatment. Aberrant …

Background: Revealing the process and mechanism of colorectal cancer will facilitate the
discovery of new biomarkers and contribute to the development of targeted drugs …

The availability of data from profiling of cancer patients with multiomics is rapidly increasing.
However, integrative analysis of such data for personalized target identification is not trivial …

Aims: Inflammatory bowel disease-associated colorectal carcinomas are known to have
different morphology, immunoprofile, and genetic findings from sporadic colorectal …

Colorectal carcinoma (CRC) represents one of the most commonly diagnosed malignant
tumors worldwide. In spite of the continuous progress in diagnostic and therapeutic tools …